Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Jean-Charles Soria

1-50 of 558 results

View this query on the Wikidata Query Service
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

scientific article (publication date: 21 May 2015)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

scientific article (publication date: 27 November 2014)
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

scientific article
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

scientific article published on 2 November 2017
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

scientific article
Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer

scientific article published on 18 November 2017
Immune-related adverse events with immune checkpoint blockade: a comprehensive review

scientific article
Management of non-small-cell lung cancer: recent developments

scientific article published on August 24, 2013
Rociletinib in EGFR-mutated non-small-cell lung cancer

scientific article
Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1.

scientific article
First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study.

scientific article published on 23 January 2017
Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non-small-cell lung cancer

scientific article published on 17 May 2010
Cutaneous side-effects of kinase inhibitors and blocking antibodies

scientific article
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT).

scientific article published on 14 January 2016
A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas

scientific article
ERCC1 isoform expression and DNA repair in non-small-cell lung cancer

scientific article
Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer

scientific article published on October 4, 2011
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial

scientific article published on 05 July 2015
Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper

scientific article
Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination

scientific article
Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation

scientific article
Management of hypertension in angiogenesis inhibitor-treated patients

scientific article published on 15 January 2009
Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial

scientific article published on 6 July 2015
Fibroblast growth factor receptor inhibitors as a cancer treatment: from a biologic rationale to medical perspectives

scientific article published on 15 February 2013
Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer

scientific article
Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC.

scientific article published on 12 August 2015
Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer

scientific article
Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors

scientific article published on 31 August 2015
Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab

scientific article
High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial

scientific article published on 01 April 2017
Exomics and immunogenics: Bridging mutational load and immune checkpoints efficacy

scientific article published on 16 January 2014
The Evolving Role of Histology in the Management of Advanced Non–Small-Cell Lung Cancer

scientific article published on November 15, 2010
Phase I Study of Everolimus Plus Weekly Paclitaxel and Trastuzumab in Patients With Metastatic Breast Cancer Pretreated With Trastuzumab

scientific article published on October 25, 2010
Targeting FGFR Signaling in Cancer

scientific article published on June 2015
EGFR-independent mechanisms of acquired resistance to AZD9291 in EGFR T790M-positive NSCLC patients

scientific article
Squamous Cell Carcinoma of the Lung: Molecular Subtypes and Therapeutic Opportunities

scientific article published on March 8, 2012
Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer

scientific article
VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management

scientific article published on 16 December 2009
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

scientific article
Assessment of the PD-L1 status by immunohistochemistry: challenges and perspectives for therapeutic strategies in lung cancer patients

scientific article published on February 25, 2016
Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600–Mutant Anaplastic Thyroid Cancer

scientific article published on October 26, 2017
Benefits of Adding a Drug to a Single-Agent or a 2-Agent Chemotherapy Regimen in Advanced Non–Small-Cell Lung Cancer

scientific article published on 01 July 2004
Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy

scientific article
Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors

scientific article
Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis.

scientific article
Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication

scientific article (publication date: August 2000)
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy

scientific article published on 01 November 2018
Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer

scientific article
Phase I study of neratinib in combination with temsirolimus in patients with human epidermal growth factor receptor 2-dependent and other solid tumors

scientific article published on 9 December 2013
Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy

scientific article published on 10 April 2016

Paulina is supported by:

About Paulina

Help